Under and Over Rehabilitation Study
Under & Over: A Controlled Study to Develop an Upper Limb Rehabilitation Tool for People With Multiple Sclerosis.
1 other identifier
interventional
120
1 country
1
Brief Summary
Multiple Sclerosis (MS) is a progressive neurological condition of the central nervous system for which there is no cure. Symptoms include motor and sensory dysfunction, bladder and bowel dysfunction as well as speech and swallowing difficulties. It commonly leads to cumulative, mixed disabilities over time. The combination of different symptoms and disabilities often limits a person's ability to perform activities of daily living and to actively participate in social and occupational activities which then impacts on their quality of life. The two main strategies for managing MS symptoms include, medication and rehabilitation. However, historically treatment strategies have focused predominantly on preserving lower limb function thus strategies to improve upper limb function is often neglected. The importance of maintaining upper limb (hand and arm) function is significant for people who have already lost lower limb function. Further loss of functioning contributes to low mood, reduced independence and quality of life. This study aims to research how an engaging everyday activity, Under \& Over, can become a rehabilitation tool to improve upper limb function in people with MS. The study will use a randomised wait list control group design, meaning that participants will be randomised to either the immediate rehabilitation group or the wait list group. Each group will perform the Under \& Over task for 12 weeks, following a predetermined programme of instructions. Participants will complete a number of baseline measures measuring their current upper limb function, their quality of life and level of fatigue. This will happen at the start of the study, after 12 weeks of rehabilitation activity and again at a 12 week follow up.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable multiple-sclerosis
Started Sep 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 20, 2020
CompletedFirst Posted
Study publicly available on registry
July 28, 2020
CompletedStudy Start
First participant enrolled
September 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2022
CompletedNovember 18, 2022
July 1, 2020
1.6 years
July 20, 2020
November 15, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Cardboard 9 Hole Peg Test speed at 6 months.
The primary outcome measure will be the self-administered Cardboard Nine Hole Peg Test (c9HPT), the raw scores are times to complete the standard task used in the assessment. The aim is to determine if repeated use of the Under \& Over tool can improve upper limb function for people with MS using the cardboard nine hole peg test. Raw 9HPT times are skewed rather than normal (Gaussian), but transforming the task times by taking their reciprocal (1/time) leads to an approximately normally distributed measure, and in this form 9HPT is standardly analysed. This reciprocal is readily interpreted as task speed: e.g. if a patient takes 25 seconds to complete the task, the reciprocal, 0.04, is the fraction of the 9HPT task achieved in one second, ie. 4%.
Baseline and 6 months
Study Arms (3)
1
ACTIVE COMPARATORParticipants in Arm 1 will be posted the Under \& Over study pack (1) and asked to complete the Under \& Over tool daily for up to 30 minutes per day, 5 days per week for 3 months. They will be instructed to follow the instruction booklet and complete each pattern in the specific order described in the booklet.
2
ACTIVE COMPARATORParticipants in Arm 2 will be posted the Under \& Over study pack (2) and asked to complete the Under \& Over tool daily for as long or short as they choose or are able to. They will be asked to complete 5 days per week for 3 months. They will be instructed to follow the instruction booklet in any order they wish, choosing which pattern they would like to complete. They will also be encouraged to create their own patterns. These participants will have access to a section of the study website where they will be able to upload photographs of their patterns and see other participants' patterns over the 3-month period.
3
PLACEBO COMPARATORParticipants in Arm 3 will be posted the Under \& Over study pack (3). For the first three months of the study they will be asked to complete the c9HPT 5 days a week. After three months, they will be able to complete the Under \& Over tool daily for as long or short as they choose. Similar to Arm 2, They will be asked to do this 5 days per week for 3 months. They will be instructed to follow the instruction booklet in any order they wish, choosing which pattern they would like to
Interventions
Under \& Over is a tool consisting of a 40cm x 40cm white plastic board, two coloured laces and a series of patterns to complete. It enables people to create patterns by threading each lace under, and over the board. It has been designed and developed with people whose upper limb function is affected by their MS. Administration time can be dependent on the person completing it.
Eligibility Criteria
You may qualify if:
- Being able to give online informed consent.
- Over the age of 18. There is no upper age limit.
- Have been diagnosed with Multiple Sclerosis more than 6 months ago and have an Expanded Disability Status Scale (EDSS) of over 6.0 as measured using the online webEDSS
- Understand and be able to communicate (read and write) in English
- Ability to use a computer and access the study resources on the internet
You may not qualify if:
- Patients unable to use their hands because of pain or anything that would interfere with the ability to complete the study interventions.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Queen Mary University of Londonlead
- Roche Pharma AGcollaborator
- Barts & The London NHS Trustcollaborator
Study Sites (1)
Queen Mary University of London
London, EC1M 6BQ, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Masking Details
- Randomisation will be done by the researcher and will be blinded to participants' identification.
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 20, 2020
First Posted
July 28, 2020
Study Start
September 1, 2020
Primary Completion
April 1, 2022
Study Completion
May 1, 2022
Last Updated
November 18, 2022
Record last verified: 2020-07